ロード中...
Profile of panitumumab as first-line treatment in patients with wild-type KRAS metastatic colorectal cancer
Targeted therapies against EGFR, vascular endothelial growth factor, and vascular endothelial growth factor receptor have expanded treatment options for patients with metastatic colorectal cancer (mCRC). Unfortunately, biomarkers to identify patients that are most likely to derive benefit from targe...
保存先:
| 出版年: | Onco Targets Ther |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4706127/ https://ncbi.nlm.nih.gov/pubmed/26770060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S68558 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|